Merus N.V. (MRUS)
NASDAQ: MRUS · Real-Time Price · USD
41.85
-0.24 (-0.57%)
Dec 20, 2024, 4:00 PM EST - Market closed
Merus Market Cap
Merus has a market cap or net worth of $2.87 billion as of December 20, 2024. Its market cap has increased by 100.43% in one year.
Market Cap
2.87B
Enterprise Value
2.09B
1-Year Change
100.43%
Ranking
Category
Stock Price
$41.85
Market Cap Chart
Since May 19, 2016, Merus's market cap has increased from $143.00M to $2.87B, an increase of 1,903.64%. That is a compound annual growth rate of 41.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 2.87B | 80.46% |
| Dec 29, 2023 | 1.59B | 121.65% |
| Dec 30, 2022 | 716.30M | -41.96% |
| Dec 31, 2021 | 1.23B | 142.03% |
| Dec 31, 2020 | 509.90M | 55.03% |
| Dec 31, 2019 | 328.90M | 20.92% |
| Dec 31, 2018 | 272.00M | -12.85% |
| Dec 29, 2017 | 312.10M | 3.83% |
| Dec 30, 2016 | 300.60M | 110.21% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xenon Pharmaceuticals | 2.97B |
| Warby Parker | 2.92B |
| Edgewise Therapeutics | 2.92B |
| Amicus Therapeutics | 2.91B |
| QuidelOrtho | 2.89B |
| Zai Lab | 2.84B |
| ACADIA Pharmaceuticals | 2.78B |
| Amedisys | 2.74B |